These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17054609)

  • 21. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population.
    Al-Daghri NM
    Saudi Med J; 2007 Mar; 28(3):339-46. PubMed ID: 17334456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.
    Lorenzo C; Williams K; Hunt KJ; Haffner SM
    Diabetes Care; 2007 Jan; 30(1):8-13. PubMed ID: 17192325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
    Song SH; Hardisty CA
    QJM; 2008 Jun; 101(6):487-91. PubMed ID: 18353792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probable blind spot in the International Diabetes Federation definition of metabolic syndrome.
    Chen HJ; Pan WH
    Obesity (Silver Spring); 2007 May; 15(5):1096-100. PubMed ID: 17495185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study.
    Mannucci E; Monami M; Cresci B; Pala L; Bardini G; Petracca MG; Dicembrini I; Pasqua A; Buiatti E; Rotella CM
    Diabetes Obes Metab; 2008 May; 10(5):430-5. PubMed ID: 17419722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotyping for early predictors of obesity and the metabolic syndrome.
    Dulloo AG; Montani JP
    Int J Obes (Lond); 2010 Dec; 34 Suppl 2():S1-3. PubMed ID: 21151141
    [No Abstract]   [Full Text] [Related]  

  • 30. [Angiopathies of type II diabetes].
    Standl E
    Verh Dtsch Ges Inn Med; 1986; 92():579-86. PubMed ID: 3811558
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population.
    Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J;
    Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tropical diabetic hand syndrome--Indian experience.
    Bajaj S; Bajaj AK
    J Assoc Physicians India; 1999 Nov; 47(11):1118-9. PubMed ID: 10862329
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk of development of chronic kidney disease in patients with type 2 diabetes having metabolic syndrome.
    Moin S; Gondal GM; Bano U
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):472-6. PubMed ID: 18798582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic criteria for metabolic syndrome: a comparative analysis in an unselected sample of adult male population.
    Strazzullo P; Barbato A; Siani A; Cappuccio FP; Versiero M; Schiattarella P; Russo O; Avallone S; della Valle E; Farinaro E
    Metabolism; 2008 Mar; 57(3):355-61. PubMed ID: 18249207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IDF and ATP-III definitions of metabolic syndrome in the prediction of all-cause mortality in type 2 diabetic patients.
    Monami M; Marchionni N; Masotti G; Mannucci E
    Diabetes Obes Metab; 2007 May; 9(3):350-3. PubMed ID: 17391162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study.
    Gorter PM; Visseren FL; Algra A; van der Graaf Y;
    Diabet Med; 2007 Dec; 24(12):1352-60. PubMed ID: 18042079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The metabolic syndrome: in need of a global mission statement.
    Cameron AJ; Zimmet PZ; Shaw JE; Alberti KG
    Diabet Med; 2009 Mar; 26(3):306-9. PubMed ID: 19317827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The metabolic syndrome.
    Meigs JB
    BMJ; 2003 Jul; 327(7406):61-2. PubMed ID: 12855493
    [No Abstract]   [Full Text] [Related]  

  • 39. Early manifestation of macrovasculopathy in newly diagnosed never treated type II diabetic patients with no traditional CVD risk factors.
    Rahman S; Ismail AA; Ismail SB; Naing NN; Rahman AR
    Diabetes Res Clin Pract; 2008 May; 80(2):253-8. PubMed ID: 18249457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic intravascular coagulation in diabetic microangiopathy patients].
    Velikov VK; Bokarev IN; Galkina AK; Shubina OI; Saltykov BB
    Klin Med (Mosk); 1985 Apr; 63(4):96-9. PubMed ID: 4033012
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.